Cargando…

Lung flute improves symptoms and health status in COPD with chronic bronchitis: A 26 week randomized controlled trial

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by mucus hypersecretion that contributes to disease related morbidity and is associated with increased mortality. The Lung Flute® is a new respiratory device that produces a low frequency acoustic wave with moderately vigorous...

Descripción completa

Detalles Bibliográficos
Autores principales: Sethi, Sanjay, Yin, Jingjing, Anderson, Pamela K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299801/
https://www.ncbi.nlm.nih.gov/pubmed/25625006
http://dx.doi.org/10.1186/s40169-014-0029-y
_version_ 1782353442235219968
author Sethi, Sanjay
Yin, Jingjing
Anderson, Pamela K
author_facet Sethi, Sanjay
Yin, Jingjing
Anderson, Pamela K
author_sort Sethi, Sanjay
collection PubMed
description BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by mucus hypersecretion that contributes to disease related morbidity and is associated with increased mortality. The Lung Flute® is a new respiratory device that produces a low frequency acoustic wave with moderately vigorous exhalation to increase mucus clearance. We hypothesized that the Lung Flute, used on a twice daily basis will provide clinical benefit to patients with COPD with chronic bronchitis. METHODS: We performed a 26 week randomized, non-intervention controlled, single center, open label trial in 69 patients with COPD and Chronic Bronchitis. The primary endpoint was change in respiratory symptoms measured with the Chronic COPD Questionnaire (CCQ). Secondary endpoints included health status, assessed by the St. George Respiratory questionnaire (SGRQ), BODE (Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity) index score and exacerbation frequency. RESULTS: While the control patients did not demonstrate any significant changes in the primary endpoint (CCQ change at 26 weeks of +0.01, p = 0.8), a trend (p = 0.08) to decrease (improvement) in the CCQ (-0.23 at 26 weeks) was seen with the Lung Flute. Furthermore, a significant improvement in the symptom domain of the CCQ was seen only with the lung flute (-0.42, p = 0.004). Health status (SGRQ) improvement, was also only seen with the Lung Flute (-3.23, p = 0.03). The BODE score increased in the control group (3.31 at baseline, 4.14 at 26 weeks), however it remained stable in the Lung Flute arm (3.16 at baseline and 26 weeks), with the changes from baseline being significantly different between the 2 arms (p = 0.01). There was a trend for less exacerbations in the Lung Flute group (p = 0.07). Adverse effects were minor, with only 1 patient discontinuing treatment because of lack of efficacy. Serious adverse effects seen were all determined to be unrelated to the device use. CONCLUSIONS: The Lung Flute is a safe and effective treatment in COPD with chronic bronchitis, providing a wide array of benefits. CLINICALTRIALS.GOV IDENTIFIER: NCT01186822
format Online
Article
Text
id pubmed-4299801
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer
record_format MEDLINE/PubMed
spelling pubmed-42998012015-01-26 Lung flute improves symptoms and health status in COPD with chronic bronchitis: A 26 week randomized controlled trial Sethi, Sanjay Yin, Jingjing Anderson, Pamela K Clin Transl Med Research BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by mucus hypersecretion that contributes to disease related morbidity and is associated with increased mortality. The Lung Flute® is a new respiratory device that produces a low frequency acoustic wave with moderately vigorous exhalation to increase mucus clearance. We hypothesized that the Lung Flute, used on a twice daily basis will provide clinical benefit to patients with COPD with chronic bronchitis. METHODS: We performed a 26 week randomized, non-intervention controlled, single center, open label trial in 69 patients with COPD and Chronic Bronchitis. The primary endpoint was change in respiratory symptoms measured with the Chronic COPD Questionnaire (CCQ). Secondary endpoints included health status, assessed by the St. George Respiratory questionnaire (SGRQ), BODE (Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity) index score and exacerbation frequency. RESULTS: While the control patients did not demonstrate any significant changes in the primary endpoint (CCQ change at 26 weeks of +0.01, p = 0.8), a trend (p = 0.08) to decrease (improvement) in the CCQ (-0.23 at 26 weeks) was seen with the Lung Flute. Furthermore, a significant improvement in the symptom domain of the CCQ was seen only with the lung flute (-0.42, p = 0.004). Health status (SGRQ) improvement, was also only seen with the Lung Flute (-3.23, p = 0.03). The BODE score increased in the control group (3.31 at baseline, 4.14 at 26 weeks), however it remained stable in the Lung Flute arm (3.16 at baseline and 26 weeks), with the changes from baseline being significantly different between the 2 arms (p = 0.01). There was a trend for less exacerbations in the Lung Flute group (p = 0.07). Adverse effects were minor, with only 1 patient discontinuing treatment because of lack of efficacy. Serious adverse effects seen were all determined to be unrelated to the device use. CONCLUSIONS: The Lung Flute is a safe and effective treatment in COPD with chronic bronchitis, providing a wide array of benefits. CLINICALTRIALS.GOV IDENTIFIER: NCT01186822 Springer 2014-09-23 /pmc/articles/PMC4299801/ /pubmed/25625006 http://dx.doi.org/10.1186/s40169-014-0029-y Text en Copyright © 2014 Sethi et al.; licensee Springer. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research
Sethi, Sanjay
Yin, Jingjing
Anderson, Pamela K
Lung flute improves symptoms and health status in COPD with chronic bronchitis: A 26 week randomized controlled trial
title Lung flute improves symptoms and health status in COPD with chronic bronchitis: A 26 week randomized controlled trial
title_full Lung flute improves symptoms and health status in COPD with chronic bronchitis: A 26 week randomized controlled trial
title_fullStr Lung flute improves symptoms and health status in COPD with chronic bronchitis: A 26 week randomized controlled trial
title_full_unstemmed Lung flute improves symptoms and health status in COPD with chronic bronchitis: A 26 week randomized controlled trial
title_short Lung flute improves symptoms and health status in COPD with chronic bronchitis: A 26 week randomized controlled trial
title_sort lung flute improves symptoms and health status in copd with chronic bronchitis: a 26 week randomized controlled trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299801/
https://www.ncbi.nlm.nih.gov/pubmed/25625006
http://dx.doi.org/10.1186/s40169-014-0029-y
work_keys_str_mv AT sethisanjay lungfluteimprovessymptomsandhealthstatusincopdwithchronicbronchitisa26weekrandomizedcontrolledtrial
AT yinjingjing lungfluteimprovessymptomsandhealthstatusincopdwithchronicbronchitisa26weekrandomizedcontrolledtrial
AT andersonpamelak lungfluteimprovessymptomsandhealthstatusincopdwithchronicbronchitisa26weekrandomizedcontrolledtrial